Charles Schwab Investment Management Inc Neogenomics Inc Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,134,651 shares of NEO stock, worth $16.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,134,651
Previous 1,076,974 5.36%
Holding current value
$16.2 Million
Previous $14.9 Million 12.04%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$13.4 - $17.73 $772,871 - $1.02 Million
57,677 Added 5.36%
1,134,651 $16.7 Million
Q2 2024

Aug 12, 2024
SELL
$13.01 - $15.77 $10,967 - $13,294
-843 Reduced 0.08%
1,076,974 $14.9 Million
Q1 2024

May 08, 2024
BUY
$14.06 - $16.79 $439,403 - $524,721
31,252 Added 2.99%
1,077,817 $16.9 Million
Q4 2023

Feb 06, 2024
BUY
$11.67 - $20.73 $487,735 - $866,389
41,794 Added 4.16%
1,046,565 $16.9 Million
Q3 2023

Nov 08, 2023
BUY
$12.15 - $17.85 $199,879 - $293,650
16,451 Added 1.66%
1,004,771 $12.4 Million
Q2 2023

Aug 09, 2023
BUY
$14.1 - $19.83 $227,630 - $320,135
16,144 Added 1.66%
988,320 $15.9 Million
Q1 2023

May 11, 2023
SELL
$9.09 - $19.45 $35,314 - $75,563
-3,885 Reduced 0.4%
972,176 $16.9 Million
Q4 2022

Feb 13, 2023
BUY
$6.45 - $12.07 $194,989 - $364,888
30,231 Added 3.2%
976,061 $9.02 Million
Q3 2022

Nov 14, 2022
BUY
$7.86 - $12.91 $98,902 - $162,446
12,583 Added 1.35%
945,830 $8.14 Million
Q2 2022

Aug 15, 2022
BUY
$7.06 - $13.97 $113,411 - $224,414
16,064 Added 1.75%
933,247 $7.61 Million
Q1 2022

May 13, 2022
BUY
$12.15 - $35.28 $250,241 - $726,626
20,596 Added 2.3%
917,183 $11.1 Million
Q4 2021

Feb 11, 2022
BUY
$30.49 - $48.49 $565,223 - $898,907
18,538 Added 2.11%
896,587 $30.6 Million
Q3 2021

Nov 16, 2021
BUY
$41.66 - $52.52 $1.32 Million - $1.66 Million
31,631 Added 3.74%
878,049 $42.4 Million
Q2 2021

Aug 16, 2021
BUY
$36.62 - $51.69 $923,849 - $1.3 Million
25,228 Added 3.07%
846,418 $38.2 Million
Q1 2021

May 17, 2021
BUY
$41.56 - $59.88 $2.15 Million - $3.09 Million
51,651 Added 6.71%
821,190 $39.6 Million
Q4 2020

Feb 16, 2021
SELL
$36.08 - $56.47 $546,215 - $854,899
-15,139 Reduced 1.93%
769,539 $41.4 Million
Q3 2020

Nov 13, 2020
SELL
$33.26 - $40.48 $266,978 - $324,932
-8,027 Reduced 1.01%
784,678 $28.9 Million
Q2 2020

Aug 14, 2020
BUY
$24.21 - $31.02 $2.37 Million - $3.04 Million
98,047 Added 14.11%
792,705 $24.6 Million
Q1 2020

May 15, 2020
BUY
$20.5 - $34.53 $248,480 - $418,538
12,121 Added 1.78%
694,658 $19.2 Million
Q4 2019

Feb 07, 2020
BUY
$18.96 - $29.84 $300,952 - $473,650
15,873 Added 2.38%
682,537 $20 Million
Q3 2019

Nov 08, 2019
BUY
$19.12 - $26.24 $1.91 Million - $2.62 Million
99,910 Added 17.63%
666,664 $12.7 Million
Q2 2019

Aug 09, 2019
BUY
$19.57 - $24.1 $1.03 Million - $1.27 Million
52,594 Added 10.23%
566,754 $12.4 Million
Q1 2019

May 14, 2019
BUY
$12.14 - $20.46 $801,070 - $1.35 Million
65,986 Added 14.72%
514,160 $10.5 Million
Q4 2018

Feb 14, 2019
BUY
$11.24 - $18.5 $753,821 - $1.24 Million
67,066 Added 17.6%
448,174 $5.65 Million
Q3 2018

Nov 13, 2018
BUY
$12.5 - $15.38 $1.03 Million - $1.26 Million
82,066 Added 27.44%
381,108 $5.85 Million
Q2 2018

Aug 08, 2018
SELL
$7.99 - $14.05 $55,554 - $97,689
-6,953 Reduced 2.27%
299,042 $3.92 Million
Q1 2018

May 07, 2018
BUY
$7.23 - $8.76 $64,701 - $78,393
8,949 Added 3.01%
305,995 $2.5 Million
Q4 2017

Jan 17, 2018
BUY
$8.02 - $11.18 $689,768 - $961,547
86,006 Added 40.75%
297,046 $2.63 Million
Q3 2017

Nov 13, 2017
BUY
$9.11 - $11.26 $1.92 Million - $2.38 Million
211,040
211,040 $2.35 Million

Others Institutions Holding NEO

# of Institutions
293
Shares Held
125M
Call Options Held
698K
Put Options Held
120K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.8B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email